Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Syngenta, UMass, and More


Title: MADS Gene Regulatory Sequences for Expressing Gene Products in Plant Reproductive Tissue

Patent Number: 8,679,844

Filed: Oct. 28, 2011

Lead Inventor: Michael Nuccio, Syngenta

Title: RNA Interference for the Treatment of Gain-of-function Disorders

Patent Number: 8,680,063

Filed: Dec. 13, 2010

Lead Inventor: Neil Aronin, University of Massachusetts

Title: shRNA Gene Therapy for Treatment of Ischemic Heart Disease

Patent Number: 8,680,064

Filed: Sept. 15, 2009

Lead Inventor: Joseph Wu, Stanford University

Title: Methods for Producing Inducible and/or Repressible Expression Active Linear RNA Interference Cassettes and Inducible and/or Repressible Expression Active Linear Gene Cassettes and Their Use

Patent Number: 8,680,256

Filed: May 25, 2009

Inventor: Khalid Abu Khabar, King Faisal Specialist Hospital & Research Center

Title: Use of microRNAs to Control Virus Helper Nucleic Acids

Patent Number: 8,680,258

Filed: Nov. 25, 2009

Lead Inventor: Vernon Coffield, Alphavax

Title: Compositions of a Peptide Targeting System for Treating Cancer

Patent Number: 8,680,045

Filed: Nov. 1, 2011

Lead Inventor: Thomas Primiano, PeptiMed

Title: Targeting microRNAs for the Treatment of Cancer

Patent Number: 8,680,067

Filed: May 25, 2012

Lead Inventor: Frank Bennett, Regulus Therapeutics